Cipla Multibagger Trgt -2 yrs Price is 600 Rs

• Cipla’s journey began in 1935 when our founder, Dr. K. A. Hamied, set up an enterprise with the vision to make India self-sufficient in healthcare. Over the past 77 years, we have emerged as one of the world’s most respected pharmaceutical names, not just in India but worldwide.
• They have 34 state-of-the-art manufacturing facilities that make Active Pharmaceutical Ingredients (APIs) and formulations, which have been approved by major international Regulatory Agencies. 
• They have over 2000 products in 65 therapeutic categories; with over 40 dosage forms, covering a wide spectrum of diseases ranging from communicable, non-communicable, common and emerging diseases to even rare diseases.
• They are not only focused on profit but also on giving cheap drugs to users . In 2012, they  reduced the prices of cancer drugs, thus making world-class medicines affordable and accessible to cancer patients.
• This has giving a huge brand and love making Cipla the mosy preferred drug maker in emerging countries.
• Avg EPS has increased by 25% YoY.
• One can expect the stock to touch 600 Rs in 2 yrs timeframe.